Literature DB >> 31219704

Exercise training intensity determination in cardiovascular rehabilitation: Should the guidelines be reconsidered?

Dominique Hansen1,2,3, Kim Bonné2, Toon Alders2, Ann Hermans2, Katrien Copermans2, Hans Swinnen2, Vincent Maris1, Thomas Jansegers1, Wout Mathijs1, Laura Haenen1, Johan Vaes2, Emmanuela Govaerts2, Veerle Reenaers2, Ines Frederix2,3,4, Paul Dendale2,3.   

Abstract

AIMS: In the rehabilitation of cardiovascular disease patients a correct determination of the endurance-type exercise intensity is important to generate health benefits and preserve medical safety. It remains to be assessed whether the guideline-based exercise intensity domains are internally consistent and agree with physiological responses to exercise in cardiovascular disease patients.
METHODS: A total of 272 cardiovascular disease patients without pacemaker executed a maximal cardiopulmonary exercise test on bike (peak respiratory gas exchange ratio >1.09), to assess peak heart rate (HRpeak), oxygen uptake (VO2peak) and cycling power output (Wpeak). The first and second ventilatory threshold (VT1 and VT2, respectively) was determined and extrapolated to %VO2peak, %HRpeak, %heart rate reserve (%HRR) and %Wpeak for comparison with guideline-based exercise intensity domains.
RESULTS: VT1 was noted at 62 ± 10% VO2peak, 75 ± 10% HRpeak, 42 ± 14% HRR and 47 ± 11% Wpeak, corresponding to the high intensity exercise domain (for %VO2peak and %HRpeak) or low intensity exercise domain (for %Wpeak and %HRR). VT2 was noted at 84 ± 9% VO2peak, 88 ± 8% HRpeak, 74 ± 15% HRR and 76 ± 11% Wpeak, corresponding to the high intensity exercise domain (for %HRR and %Wpeak) or very hard exercise domain (for %HRpeak and %VO2peak). At best (when using %Wpeak) in only 63% and 72% of all patients VT1 and VT2, respectively, corresponded to the same guideline-based exercise intensity domain, but this dropped to about 48% and 52% at worst (when using %HRR and %HRpeak, respectively). In particular, the patient's VO2peak related to differently elicited guideline-based exercise intensity domains (P < 0.05).
CONCLUSION: The guideline-based exercise intensity domains for cardiovascular disease patients seem inconsistent, thus reiterating the need for adjustment.

Entities:  

Keywords:  Cardiovascular rehabilitation; exercise intensity; guidelines

Year:  2019        PMID: 31219704     DOI: 10.1177/2047487319859450

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  15 in total

1.  Evaluating the Accuracy of Using Fixed Ranges of METs to Categorize Exertional Intensity in a Heterogeneous Group of Healthy Individuals: Implications for Cardiorespiratory Fitness and Health Outcomes.

Authors:  Danilo Iannetta; Daniel A Keir; Federico Y Fontana; Erin Calaine Inglis; Anmol T Mattu; Donald H Paterson; Silvia Pogliaghi; Juan M Murias
Journal:  Sports Med       Date:  2021-04-26       Impact factor: 11.136

2.  The Effects of Standardised versus Individualised Aerobic Exercise Prescription on Fitness-Fatness Index in Sedentary Adults: A Randomised Controlled Trial.

Authors:  Michael J Kirton; Mitchel T Burnley; Joyce S Ramos; Ryan Weatherwax; Lance C Dalleck
Journal:  J Sports Sci Med       Date:  2022-09-01       Impact factor: 4.017

Review 3.  Optimal aerobic exercise intensity and its influence on the effectiveness of exercise therapy in patients with pulmonary arterial hypertension: a systematic review.

Authors:  Yong-Gon Seo; Suki Oh; Won-Hah Park; Mija Jang; Ho-Young Kim; Sung-A Chang; In-Kyung Park; Jidong Sung
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

Review 4.  Identification of Non-Invasive Exercise Thresholds: Methods, Strategies, and an Online App.

Authors:  Daniel A Keir; Danilo Iannetta; Felipe Mattioni Maturana; John M Kowalchuk; Juan M Murias
Journal:  Sports Med       Date:  2021-10-25       Impact factor: 11.136

5.  Training intensity and improvements in exercise capacity in elderly patients undergoing European cardiac rehabilitation - the EU-CaRE multicenter cohort study.

Authors:  Thimo Marcin; Prisca Eser; Eva Prescott; Leonie F Prins; Evelien Kolkman; Wendy Bruins; Astrid E van der Velde; Carlos Peña Gil; Marie-Christine Iliou; Diego Ardissino; Uwe Zeymer; Esther P Meindersma; Arnoud W J Van't Hof; Ed P de Kluiver; Matthias Wilhelm
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

6.  Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes.

Authors:  Valeria Conti; Graziamaria Corbi; Maria Vincenza Polito; Michele Ciccarelli; Valentina Manzo; Martina Torsiello; Emanuela De Bellis; Federica D'Auria; Gennaro Vitulano; Federico Piscione; Albino Carrizzo; Paola Di Pietro; Carmine Vecchione; Nicola Ferrara; Amelia Filippelli
Journal:  Biomolecules       Date:  2020-11-23

Review 7.  The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure.

Authors:  Aneta Aleksova; Milijana Janjusevic; Giulia Gagno; Alessandro Pierri; Laura Padoan; Alessandra Lucia Fluca; Cosimo Carriere; Antonio Paolo Beltrami; Gianfranco Sinagra
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

Review 8.  [Resistance exercise training in cardiac rehabilitation].

Authors:  M Koch; J-P Broustet
Journal:  Arch Mal Coeur Vaiss Pratique       Date:  2020-05-22

9.  UK cardiac rehabilitation fit for purpose? A community-based observational cohort study.

Authors:  Saïd Ibeggazene; Chelsea Moore; Costas Tsakirides; Michelle Swainson; Theocharis Ispoglou; Karen Birch
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

10.  The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects.

Authors:  Francesca Anselmi; Luna Cavigli; Antonio Pagliaro; Serafina Valente; Francesca Valentini; Matteo Cameli; Marta Focardi; Nicola Mochi; Paul Dendale; Dominique Hansen; Marco Bonifazi; Martin Halle; Flavio D'Ascenzi
Journal:  Scand J Med Sci Sports       Date:  2021-07-05       Impact factor: 4.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.